Financial results - PUNTA PHARM S.R.L.

Financial Summary - Punta Pharm S.r.l.
Unique identification code: 33840152
Registration number: J23/2980/2021
Nace: 4646
Sales - Ron
10.796
Net Profit - Ron
1.029
Employee
The most important financial indicators for the company Punta Pharm S.r.l. - Unique Identification Number 33840152: sales in 2023 was 10.796 euro, registering a net profit of 1.029 euro and having an average number of employees. Firma isi desfasoara activitatea in domeniul Comert cu ridicata al produselor farmaceutice having the NACE code 4646.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Punta Pharm S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 0 31.572 45.026 26.140 18.591 16.282 5.654 14.638 1.169 10.796
Total Income - EUR 0 31.572 45.161 26.274 18.591 16.289 5.663 14.729 1.219 10.828
Total Expenses - EUR 707 59.939 46.480 36.028 27.512 25.889 12.496 14.652 7.257 9.683
Gross Profit/Loss - EUR -707 -28.367 -1.318 -9.754 -8.920 -9.600 -6.832 77 -6.038 1.146
Net Profit/Loss - EUR -707 -29.314 -2.220 -10.538 -9.479 -10.042 -6.987 -362 -6.073 1.029
Employees 0 1 1 0 0 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 826.3%, from 1.169 euro in the year 2022, to 10.796 euro in 2023. The Net Profit increased by 1.029 euro, from 0 euro in 2022, to 1.029 in the last year.

Check the financial reports for the company - Punta Pharm S.r.l.

Rating financiar

Financial Rating -
Punta Pharm S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Punta Pharm S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Punta Pharm S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Punta Pharm S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Punta Pharm S.r.l. - CUI 33840152

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 1.013 13.093 19.540 12.194 4.441 631 28 216 412 338
Current Assets 31 20.683 43.184 38.986 31.631 38.872 31.465 40.410 38.438 51.175
Inventories 0 4.447 4.962 6.786 84 8.540 9.184 19.692 19.328 26.866
Receivables 0 15.988 31.651 27.910 26.206 30.130 21.873 20.497 19.038 23.297
Cash 31 248 6.571 4.290 5.342 202 408 221 72 1.012
Shareholders Funds 409 -28.812 -30.738 -40.756 -49.487 -57.433 -63.331 -62.289 -68.555 -67.318
Social Capital 1.116 1.215 1.202 1.182 1.160 2.276 2.233 2.183 2.190 2.183
Debts 635 62.282 93.440 91.915 85.299 97.255 95.136 103.216 107.844 119.206
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 51.175 euro in 2023 which includes Inventories of 26.866 euro, Receivables of 23.297 euro and cash availability of 1.012 euro.
The company's Equity was valued at -67.318 euro, while total Liabilities amounted to 119.206 euro. Equity increased by 1.029 euro, from -68.555 euro in 2022, to -67.318 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Punta Pharm S.r.l.

Comments - Punta Pharm S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.